Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 15,746 Shares

By Yahoo! Finance | Jul 12, 2024 at 07:09 PM EST

Mineralys Therapeutics Inc focuses on developing therapies for cardiovascular and cardiorenal diseases. Recent insider transactions, including significant share sales by Jon Congleton, have drawn attention. The company's stock is currently valued at $718.91 million, with various valuation metrics available for investors to consider.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.